
Greenwich LifeSciences Inc.
$24.43
+1.0200 (4.36%)
Latest News
Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026
Jun 01, 2026 08:15 AM
Greenwich LifeSciences Provides Update Regarding Form 10-K Filing
Jun 01, 2026 06:00 AM
Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
May 22, 2026 04:30 PM
Greenwich LifeSciences Provides Update Regarding Form 10-K Filing
Apr 30, 2026 06:00 AM
Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026
Apr 23, 2026 06:00 AM
Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
Apr 22, 2026 05:00 PM
Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026
Apr 20, 2026 06:00 AM
Greenwich LifeSciences Provides Update on Financing Strategy
Apr 14, 2026 06:00 AM
Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential
Apr 07, 2026 06:00 AM
Greenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-01
Mar 19, 2026 06:00 AM
Sign Up For GLSI Email News Alerts
Disclosure
RedChip Companies, Inc. research reports, company profiles, and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that RedChip Companies Inc. is an investor relations firm hired by certain companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles, or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and/or the Ontario Securities Commission (“OSC”) at www.osc.gov.on.ca.
Greenwich LifeSciences Inc. (GLSI) is a client of RedChip Companies, Inc. GLSI agreed to pay RedChip Companies, Inc. a $5,000 monthly cash fee, beginning in November 2024 for RedChip investor awareness services. GLSI also agreed to pay RedChip $50,000 cash fee for a national TV ad campaign aired March 17 to March 28, 2025, and a one-time $40,000 cash for a 10-day national TV ad campaign aired August 13 to August 26, 2025.
Investor awareness services and programs are designed to help small-cap companies communicate their investment characteristics. RedChip investor awareness services include the preparation of a research profile(s), multimedia marketing, and other awareness services.